U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Erlotinib (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Jan 2012 Actual patient number is 24 according to ClinicalTrials.gov.
- 17 Jan 2012 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.